The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization